Exact Mass: 1026.3751066000002
Exact Mass Matches: 1026.3751066000002
Found 20 metabolites which its exact mass value is equals to given mass value 1026.3751066000002,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bromelain
C39H66N2O29 (1026.3751066000002)
ManXylManGlcNAcFucGlcNAc
C39H66N2O29 (1026.3751066000002)
[Chemical] Source; carrot glycoprotein
Carvedilol phosphate
C48H60N4O17P2 (1026.3428529999999)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Carbohydrate moiety of bromelain
C39H66N2O29 (1026.3751066000002)
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Fucalpha1-3[Manalpha1-3(Xylbeta1-2)Manbeta1-4GlcNAcbeta]1-4GlcNAcbeta
C39H66N2O29 (1026.3751066000002)
Xylf(b1-2)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
C39H66N2O29 (1026.3751066000002)
Fucalpha1-6[Manalpha1-3(Xylbeta1-2)Manbeta1-4GlcNAcbeta1-4]GlcNAcbeta
C39H66N2O29 (1026.3751066000002)
Xyl(b1-2)[Man(b1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xyl(b1-2)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(b1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xylf(b1-2)[Fuc(a1-3)][Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
C39H66N2O29 (1026.3751066000002)
Xyl(b1-2)[Man(b1-3)]Man(b1-4)GlcNAc(a1-4)[Fuc(b1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xylf(b1-2)[Fuc(a1-3)][Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xyl(b1-2)[Fuc(a1-3)][Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Xylf(b1-2)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
Fucalpha1-3[Manalpha1-3(Xylbeta1-2)Manbeta1-4GlcNAcbeta]1-4GlcNAc
C39H66N2O29 (1026.3751066000002)
L-Xyl(b1-2)[Man(a1-6)]L-Man(b1-4)GlcNAc(b1-4)[D-Fuc(a1-3)]b-GlcNAc
C39H66N2O29 (1026.3751066000002)
RNAIII-inhibiting peptide(TFA)
C47H57F3N10O13 (1026.4058467999998)
RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis.
n-(5-{[4,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-2-({6-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl}oxy)-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid
C39H66N2O29 (1026.3751066000002)
n-[(3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-5-{[(2s,3s,4s,5s,6r)-4,5-dihydroxy-6-({[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-6-(hydroxymethyl)-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidic acid
C39H66N2O29 (1026.3751066000002)